Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NYSE

One Of America's Most Recognizable Restaurants Explores Sale Amid Identity Crisis As Yum! Brands Doubles Down On Gen Z Strategy

Yum! Brands Inc. (NYSE:YUM) said last week that it is exploring a potential sale of Pizza Hut, one of America’s most iconic pizza chains.

Benzinga

Ozempic Maker Novo Nordisk Faces Board Shakeup

On Friday, Novo Nordisk A/S' (NYSE:NVO) board director Mikael Dolsten said he will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November 2025.

Benzinga

Cathie Dumps AMD And Reddit Shares Amid Tech Bloodbath, Ark Doubles Down On Tom Lee And Peter Thiel Crypto Plays

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably involving Circle Internet Group Inc (NYSE:CRCL), Bitmine Immersion Technologies Inc (NYSE:BMNR), Bullish (NYSE:BLSH), Advanced Micro Devices Inc (NASDAQ:AMD), and Reddit Inc (NYSE:RDDT). These trades reflect Ark’s strategic positioning in the market, with particular focus on the tech and crypto sectors.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Newsmax Stock Gains On Q3 Beat, Strong Non-Election Year Growth

Media company Newsmax Inc (NYSE:NMAX) reported third-quarter financial results Thursday after market close.

Benzinga

Home Depot Could Hammer Out Gains With Pro Expansion, Analyst Says

Home Depot Inc. (NYSE:HD) reports its third-quarter earnings on November 18 and is expected to follow with an update on its strategic priorities and long-term base-case outlook at its December Analyst Conference.

Benzinga

Circle's Strong Q3 Isn't Lifting Shares — But Analysts See Big Upside Ahead

Shares of Circle Internet Group Inc. (NYSE:CRCL) remained under pressure in early trading on Wednesday, despite Tuesday’s reporting of upbeat third-quarter results.

Benzinga

As Warren Buffett Nears His Exit, Berkshire's Amassed Record Cash

After 60 years with Berkshire Hathaway, Warren Buffett is nearing retirement. In the lead-up to his exit, the firm has amassed a $381 billion cash reserve.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Trump-Endorsed GENIUS Act Provided 'Regulatory Clarity,' Fueled Circle's Strong Q3, Says CEO Jeremy Allaire

Jeremy Allaire, CEO of Circle Internet Group (NYSE:CRCL), said Wednesday that “regulatory” clarity provided by the GENIUS Act was one of the major reasons behind the company’s strong performance in the third quarter.

Benzinga

15 Stocks To Consider Buying For The Supreme Court Ruling On Trump's Tariffs

Right now, the U.S. Supreme Court is staring down a case that could unravel some of the biggest pieces of Trump's economic legacy—specifically, the recent tariffs imposed during his presidency under the International Emergency Economic Powers Act (IEEPA).

Benzinga

Bargain Buy or Risky Bet? Bath & Body Works Slides to 52-Week Low

Bath & Body Works stock hit its 25th new 52-week low of the past 12 months on Tuesday. BBWI stock is down over 30% in the past year. Four years ago, it traded at $82. It’s now about one-quarter the value.

Barchart

Circle's Record Q3 Stuns Investors — But 202% Profit Surge Doesn't Lift CRCL

Circle Internet Group Inc. (NYSE:CRCL) stunned markets on Wednesday after posting a 202% profit surge, yet the stock slid again as traders questioned whether the gains can translate into long-term growth.

Benzinga

Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch

Eli Lilly Co. (NYSE:LLY) is reportedly dropping CVS Health Inc.'s (NYSE:CVS) drug benefit plan for its employees.

Benzinga

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'

Dave Ricks, CEO of pharmaceutical giant Eli Lilly and Co. (NYSE:LLY), delivered a scathing critique of pharmacy benefit managers (PBMs), accusing the industry’s “middle actors” of “rent taking” and creating a “terrible incentive” structure that caused insulin list prices to skyrocket.

Benzinga

Google To Run Ohio Data Centers On Solar Power From TotalEnergies

TotalEnergies SE (NYSE:TTE) on Wednesday penned a 15-year Power Purchase Agreement (PPA) with Alphabet Inc.’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

$5,200 Gold Forecast Puts Mining ETFs On The Hot Seat: Opportunity Or Overreach?

Gold’s rally to record highs may be far from over. With JP Morgan Private Bank forecasting prices could exceed $5,200 per ounce by the end of 2026 and Bank of America calling for $5,000, the yellow metal is again the market’s favorite hedge against fiscal and geopolitical uncertainty. Gold ETFs,…

Benzinga

Getty Images Q3 2025 Earnings Call Transcript

Getty Images Holdings, Inc. (NYSE:GETY) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.

Benzinga

Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December

Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).

Benzinga

GlobalFoundries Secures Next-Gen Chip Tech From Taiwan Semiconductor

GlobalFoundries Inc. (NASDAQ:GFS) announced a technology licensing deal with Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM) to boost the development of advanced Gallium Nitride (GaN) chips for data centers, industrial systems, and electric vehicles.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Organon Cuts 2025 Sales Outlook Despite Earnings Beat

Organon (NYSE:OGN) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 billion, beating the Wall Street estimate of $1.56 billion.

Benzinga

Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration

MeiraGTx Holdings plc (NASDAQ:MGTX) stock is trading higher after the company inked a strategic collaboration in the area of ophthalmology with Eli Lilly and Co. (NYSE:LLY).

Benzinga

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More

The pace of earnings season slows down in the days ahead, but there are still plenty of retail-favorite names set to report this week.

International Business Times UK

Markets Turn Bullish as Senate Strikes Deal to End Record US Shutdown

Shares rose as the US Senate reached a new deal to end the longest government shutdown in the nation's history.

Benzinga

Consumer Tech News (Nov 3-7): Trump Blocks Nvidia Blackwell AI Chip Exports, China Bans Foreign AI Chips In Data Centers & More

President Donald Trump has declared that Nvidia's (NASDAQ:NVDA) advanced Blackwell AI chip will not be available for "other people." This decision comes amid concerns about the potential sale of a scaled-down version to China.

Benzinga

Visa, Mastercard Near Historic Settlement With Merchants: Could Cut Fees, Let Stores Reject Rewards Cards

Visa Inc. (NYSE:V) and Mastercard Inc. (NYSE:MA) are reportedly close to settling with merchants that could reduce credit card fees and give retailers more flexibility in deciding which cards to accept.

Benzinga

MSTR Falls To $230 Despite Strategy's Upsized Stock Offering

Strategy Inc. (NASDAQ:MSTR) announced an increase of a high-yield preferred offering to fund more Bitcoin (CRYPTO: BTC) purchases, but MSTR shares plunged to $230 as traders sold the news.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.